Aurora Sheboygan Prices – Radium Ra 223 Dichloride Treatment Costs $390
Radium Ra 223 Dichloride treatment is a specialized therapy for patients with castration-resistant prostate cancer that has spread to the bones but not to other organs. Offered at Aurora Medical Center Sheboygan County for $390, this treatment delivers targeted radiation to bone metastases, helping to relieve pain and improve quality of life. The fee generally covers the cost of the radiopharmaceutical agent and its administration, but may not include related services such as pre-treatment imaging, physician consultations, or post-treatment monitoring. Patients are advised to request an itemized estimate to clarify what is included in the quoted price and inquire about any additional associated costs.
Cost Breakdown
- Radium Ra 223 Dichloride agent: Included in the $390 fee
- Administration of the injection: Typically included, but confirm with the provider
- Pre-treatment imaging (e.g., bone scans): Usually billed separately
- Physician consultation: May be a separate charge
- Post-treatment monitoring/lab tests: Often billed separately
Associated Costs
- Additional imaging or blood tests before or after treatment
- Follow-up visits to monitor response and side effects
- Supportive medications (e.g., for pain or side effects)
- Other therapies, if recommended as part of your cancer care plan
Insurance & Payment Advice
- Check with your insurance provider to determine coverage for Radium Ra 223 Dichloride treatment and related services.
- If uninsured or underinsured, ask about financial assistance programs or payment plans offered by the facility.
- Request a detailed, itemized estimate before beginning treatment to avoid unexpected charges.
Side-Effect Considerations & Recovery Tips
- Common side effects may include mild nausea, diarrhea, or temporary drops in blood cell counts.
- Stay hydrated and notify your care team if you experience new or worsening symptoms.
- Attend all recommended follow-up appointments for monitoring and supportive care.
Frequently Asked Questions
- What is Radium Ra 223 Dichloride treatment used for?
This treatment is used for castration-resistant prostate cancer that has metastasized to the bones but not to other organs. - How does Radium Ra 223 Dichloride work?
It mimics calcium and targets bone metastases, delivering radiation directly to cancerous sites to help destroy cancer cells and relieve pain. - What is included in the $390 fee?
The fee typically covers the Radium Ra 223 Dichloride agent and its administration, but you should confirm with the provider if other services are included. - Are there additional costs beyond the listed price?
Yes, services such as imaging, lab tests, and physician consultations may not be included and could incur extra charges. - Is this treatment covered by insurance?
Certain insurance plans may cover the treatment, but coverage varies. Check with your insurer and the medical center’s billing department for details. - How is Radium Ra 223 Dichloride administered?
It is given as an intravenous injection, typically in an outpatient setting. - What side effects should I expect?
Common side effects include nausea, diarrhea, and temporary drops in blood cell counts. Serious side effects are rare but possible. - How long does the treatment take?
The injection itself is quick, but you may need to stay for observation. The full course usually involves several injections given at intervals. - Can I get financial assistance for this treatment?
Many facilities offer financial counseling and may have assistance programs. Ask the billing office about your options. - Should I get an itemized estimate before treatment?
Yes, requesting a detailed estimate helps you understand all potential charges and avoid unexpected bills. - Are there alternatives to Radium Ra 223 Dichloride?
Other treatments for bone metastases exist. Discuss with your oncologist to determine the best option for your situation.
Aurora Medical Center Sheboygan County, located at 3400 Union Ave, Sheboygan, WI, offers a specialized treatment known as Radium Ra 223 Dichloride, which is primarily used for patients with castration-resistant prostate cancer that has spread to bones but not to other organs. This treatment works by delivering targeted radiation to bone metastases, helping to alleviate pain and improve quality of life. According to Aurora Sheboygan Prices, the cost for this treatment is $390, making it a potentially accessible option for patients requiring this specific form of cancer therapy.
What is Radium Ra 223 Dichloride treatment? – Radium Ra 223 Dichloride is a radiopharmaceutical used to treat prostate cancer that has spread to the bones, providing targeted radiation to reduce pain and improve patient outcomes.
How does Radium Ra 223 Dichloride work? – It mimics calcium and binds to bone minerals, delivering radiation directly to bone tumors, which helps to destroy cancer cells while minimizing damage to surrounding healthy tissue.
Who is eligible for Radium Ra 223 Dichloride treatment? – This treatment is typically recommended for patients with castration-resistant prostate cancer that has metastasized to bones but not to other organs.
What are the potential side effects of Radium Ra 223 Dichloride? – Common side effects include nausea, diarrhea, vomiting, and low blood cell counts, though patients should discuss all potential risks with their healthcare provider.
How is Radium Ra 223 Dichloride administered? – The treatment is given as an intravenous injection, usually once every four weeks, for a total of six injections.
Is Radium Ra 223 Dichloride treatment covered by insurance? – Coverage can vary, so patients should check with their insurance provider to determine if this treatment is included in their plan.
What should patients expect during the treatment process? – Patients can expect a brief outpatient procedure for each injection, with minimal downtime, allowing them to return to their daily activities shortly after treatment.
How effective is Radium Ra 223 Dichloride in treating bone metastases? – Clinical studies have shown it can extend survival and improve quality of life by reducing bone pain and the risk of fractures in eligible patients.